Rising drug prices tough on consumers


In this Monday, Nov. 23, 2015, file photo, the Pfizer flag flies in front of world headquarters in New York. On Wednesday, Aug. 24, 2016, drugmaker Pfizer said it's buying rights to Anglo-Swedish drugmaker AstraZeneca PLC's portfolio of approved and experimental antibiotic and antifungal pills, a move to boost Pfizer's business in one of its priority areas.



from Biotech News